Owen A. O'Connor, MD, PhD^1*, Barbara Pro, M.D.², Lauren Pinter-Brown, MD^3*, Leslie Popplewell, MD⁴, Nancy Barlett, MD^5*, Andrei Shustov, MD⁶, Mary Jo Lechowicz, MD⁷, Kerry J Savage, MD, MSc⁸, Bertrand Coiffier, MD⁹, Eric Jacobsen, MD^10*, Pier Luigi Zinzani, MD^11*, Andre Goy, MD¹², Jasmine Zain, MD^1*, Shannon Wilroy^13*, Molly Patterson^1*, Adam Boyd^13*, Michael E. Saunders, MD^13*, Pablo Cagnoni, MD^13* and Steven M. Horwitz, MD¹⁴

¹CUMC, New York, NY
²Department of Lymphoma/Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
³Dept of Internal Medicine, Division of Oncology, University of California at Los Angeles, Los Angeles, CA
⁴City of Hope, Duarte, CA
⁵Department of Internal Medicine, Division of Oncology, Washington University of Medicine, St Louis, MO
⁶University of Washington, Seattle, WA
⁷Emory University, Atlanta, GA
⁸British Columbia Cancer Agency, Vancouver, BC, Canada
⁹Centre Hospitalier Lyon-Sud, Pierre-Benite
¹⁰Dana Farber, Boston, ME
¹¹Department of Hematology/Oncology, University of Bologna, Bologna, Italy
¹²Cancer Center at HUMC, Hackensack, NJ
¹³Allos Therapeutics, Inc., Westminster, CO
¹⁴Memorial Sloan-Kettering Cancer Center, New York, NY

Pier Luigi Zinzani, MD^1*, Thomas E. Witzig, MD^2*, Julie M. Vose, MD³, Craig B. Reeder, MD⁴, Rena Buckstein, MD, FRCPC⁵, Corinne Haioun⁶, Reda Bouabdallah, MD⁷, Jonathan Polikoff, MD^8*, Pingshan Guo^9*, Annette Ervin-Hayes^9*, Dennis Pietronigro^9*, Jerome B. Zeldis, MD⁹ and Myron S. Czuczman, MD¹⁰

¹Department of Hematology/Oncology, University of Bologna, Bologna, Italy
²Mayo Clinic, Rochester, MN
³Univ. of NE Med. Ctr., Omaha, NE
⁴Hematology, Mayo Clinic Arizona, Scottsdale, AZ
⁵Dept. of Hematology/Oncology, Sunnybrook Odette Cancer Center, Toronto, ON, Canada
⁶Service d'Hématologie Clinique, Hôpital Henri Mondor, Créteil, France
⁷Institut Paoli-Calmettes, Marseille, France
⁸Kaiser Permanente Medical Group, San Diego, CA
⁹Celgene Corporation, Summit, NJ
¹⁰Roswell Park Cancer Institute, Buffalo, NY

Youn Kim, MD¹, Sean Whittaker, MD, FRCP^2*, Marie France Demierre, MD^3*, Alain H Rook, MD^4*, Adam Lerner, MD⁵, Madeleine Duvic, MD⁶, Sunil Reddy, MD^1*, Ellen J Kim, MD^4*, Tadeusz Robak, MD^7*, Jürgen C Becker, MD^8*, Alexey Samtsov, MD^9*, William McCulloch, MB, FRCP^10* and Archibald G Prentice, MBChB, FRCP, FRCPath¹¹

¹Dematology, Stanford Comphrehensive Cancer Center, Stanford, CA
²St. John's Institution of Dermatology, St. Thomas' Hospital, London, United Kingdom
³Dematology, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Dematology, University of Pennsylvania, Philadelphia, PA
⁵Boston Medical Center, Boston, MA
⁶M.D. Anderson Cancer Center, The University of Texas, Houston, TX
⁷Klinika Hematologii Uniwersyteu Medycznego, Łódź, Poland
⁸Universität Würzburg, Universität Würzburg, Würzburg, Germany
⁹Dermatovenerology Department, State Educational Institution for Higher Professional Education Military Medical Academy, Saint-Petersburg, Russia
¹⁰Gloucester Pharmaceuticals, Cambridge, MA
¹¹Department of Haematology, Royal Free Hospital, London

John P. Leonard, MD¹, Ann LaCasce, MD², Mitchell R Smith, MD, PhD³, Ariela Noy, MD⁴, Jeffrey T Yap, PhD^2*, Annick D Van den Abbeele, MD^2*, Jian Q Yu, MD, FRCPC^5*, Selina Chen-Kiang, PhD⁶, Scott A Ely, MD, PhD^6*, Shankar Vallabhajosula, PhD^7*, Lucian R Chirieac, MD^2*, Steven M Larson, MD^4*, Geoffrey I Shapiro, MD, PhD^2* and Heiko Schoder^8*

¹Division of Hem./Onc., Weill Cornell Medical College, New York, NY
²Dana-Farber Cancer Inst., Boston, MA
³Fox Chase Cancer Center, Philadelphia, PA
⁴Memorial Sloan-Kettering Cancer Ctr., New York, NY
⁵Fox Chase Cancer Ctr., Philadelphia, PA
⁶Weill-Cornell Medical College, New York, NY
⁷Radiochemistry and Radiopharmacy, Weill-Cornell Medical Center, New York, NY
⁸Radiology/Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Brad Kahl¹, Julie Chang^1*, Jens Eickhoff^2*, Leslie Gilbert^1*, Eric Rogers^1*, Jae Werndli^1*, Michael Huie^3*, Thomas McFarland^3*, Michael Volk⁴, Jules H. Blank⁴, Natalie Callander^1*, Walter Longo^1* and Christopher Peterson⁵

¹Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
²Biostatistics and Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI
³University of Wisconsin Medical Foundation, Madison, WI
⁴Green Bay Oncology, Ltd., Green Bay, WI
⁵Aspirus Cancer Center, Wausau, WI

Luis Fayad¹, Hemant Patel, PhD², Gregor Verhoef^3*, Mitchell R. Smith^4*, Peter W.M. Johnson, MD, FRCP⁵, Myron S. Czuczman, MD⁶, Bertrand Coiffier^7*, Georg Hess^8*, Eva Gine^9*, Anjali Advani, MD¹⁰, Fritz Offner, MD¹¹, Erik R. Vandendries, MD, PhD¹², Mark Shapiro, MD, PhD, FACP¹² and Nam H. Dang, MD, PhD¹³

¹MD Anderson Cancer Center, Houston, TX
²Oncology, Wyeth Pharmaceuticals, Cambridge, MA
³University Hospital, Leuven, Belgium
⁴Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA
⁵Cancer Research UK Clinical Centre, University of Southampton, Southampton, United Kingdom
⁶Roswell Park Cancer Institute, Buffalo, NY
⁷Centre Hospitalier Lyon-Sud, Pierre-Benite, France
⁸Johannes Gutenberg-Universität, Mainz, Germany
⁹Hematology, Hospital Clinic de Barcelona, Barcelona, Spain
¹⁰Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
¹¹University Hospital Ghent, Gent, Belgium
¹²Wyeth Research, Cambridge, MA
¹³Nevada Cancer Institute, Las Vegas, NV

Ralf C Bargou, MD^1*, Max Topp, MD^2*, Peter Kufer, MD^3*, Mariele Goebeler, MD^4*, Stefan Knop, MD^2*, Hermann Einsele, MD⁵, Richard Noppeney, MD^6*, Andreas Viardot, MD^7*, Patrick A Baeuerle, PhD^3*, Carsten Reinhardt, MD^3*, Margit Schmidt, PhD^3*, Petra Klappers^3*, Dirk Nagorsen, MD^3* and Gerhard Zugmaier, MD^3*

¹Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
²Hematology & Oncology, Medical Center University of Wuerzburg, Wuerzburg, Germany
³Micromet AG, Munich, Germany
⁴Department of Internal Medicine II, Division of Hematology, University Hospital Würzburg
⁵Medizinische Klinik II, Wurzburg, Germany
⁶Center for Internal Medicine , Hematology, University Hospital Essen, Essen, Germany
⁷Internal Medicine III, Hematology, University Hospital Ulm, Ulm, Germany

Myron S. Czuczman, MD¹, Julie M. Vose, MD², Pier Luigi Zinzani, MD^3*, Craig B. Reeder, MD⁴, Rena Buckstein, MD, FRCPC⁵, Corinne Haioun^6*, Reda Bouabdallah, MD⁷, Jonathan Polikoff, MD^8*, Pingshan Guo^9*, Annette Ervin-Haynes^9*, Dennis Pietronigro^9*, Jerome B. Zeldis, MD⁹ and Thomas E. Witzig^10*

¹Roswell Park Cancer Institute, Buffalo, NY
²Univ. of NE Med. Ctr., Omaha, NE
³Department of Hematology/Oncology, University of Bologna, Bologna, Italy
⁴Hematology, Mayo Clinic Arizona, Scottsdale, AZ
⁵Dept. of Hematology/Oncology, Sunnybrook Odette Cancer Center, Toronto, ON, Canada
⁶Hopital Henri Mondor, Creteil, France
⁷Institut Paoli-Calmettes, Marseille, France
⁸Kaiser Permanente Medical Group, San Diego, CA
⁹Celgene Corporation, Summit, NJ
¹⁰Mayo Clinic, Rochester, MN